Cybin Inc. (HELP) Ownership
HELP ownership summary
as of October 18, 2026- Institutions
- 42.0% of shares outstanding
- Insiders
- 12.88% of shares outstanding
- Shares outstanding
- 73.1M
- Float
- 58.1M shares available to trade
- Short interest
- — 3.5M shares short
- Days to cover
- 2.02 short interest up 7.4% vs prior month
- Institutions 41.97%
- Insiders 12.88%
- Other investors 45.14%
HELP top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | VR Adviser, LLC | 5.27% | 3.9M | $40.6M | — | June 30, 2026 |
| 2 | Orbimed Advisors LLC | 4.48% | 3.3M | $34.5M | −561,443 (−14.6%) | June 30, 2026 |
| 3 | Adage Capital Partners Gp LLC | 4.19% | 3.1M | $32.3M | +2.4M (+337.1%) | June 30, 2026 |
| 4 | Millennium Management LLC | 3.60% | 2.6M | $27.8M | +216,315 (+9.0%) | June 30, 2026 |
| 5 | Rosalind Advisors, Inc. | 2.68% | 2.0M | $20.6M | +425,000 (+27.7%) | June 30, 2026 |
| 6 | Sphera Funds Management Ltd. | 2.22% | 1.6M | $17.1M | +633,663 (+64.2%) | June 30, 2026 |
| 7 | DCF Advisers, LLC | 1.96% | 1.4M | $15.1M | +743,000 (+107.4%) | June 30, 2026 |
| 8 | Sio Capital Management, LLC | 1.78% | 1.3M | $13.7M | +1.3M (0.0%) | June 30, 2026 |
| 9 | Nan Fung Group Holdings Ltd | 1.35% | 987K | $10.4M | +527,222 (+114.6%) | June 30, 2026 |
| 10 | Boxer Capital Management, LLC | 1.08% | 790K | $8.3M | +150,000 (+23.4%) | June 30, 2026 |
| 11 | Logos Global Management LP | 1.03% | 750K | $7.9M | +750,000 (0.0%) | June 30, 2026 |
| 12 | Citadel Advisors Llc | 0.85% | 621K | $6.6M | −256,388 (−29.2%) | June 30, 2026 |
| 13 | Dafna Capital Management LLC | 0.70% | 514K | $5.4M | +15,700 (+3.2%) | June 30, 2026 |
| 14 | Walleye Trading Advisors, LLC | 0.69% | 503K | $5.3M | +502,554 (0.0%) | June 30, 2026 |
| 15 | Morgan Stanley - Brokerage Accounts | 0.63% | 462K | $4.9M | −563,432 (−55.0%) | June 30, 2026 |
| 16 | Knott David M Jr | 0.51% | 370K | $3.9M | +20,000 (+5.7%) | June 30, 2026 |
| 17 | Bank of America Corp | 0.46% | 337K | $3.6M | +337,435 (0.0%) | June 30, 2026 |
| 18 | AdvisorShares Investments, LLC | 0.40% | 293K | $3.1M | +97,107 (+49.6%) | June 30, 2026 |
| 19 | Jane Street Group LLC | 0.38% | 281K | $3.0M | +174,554 (+164.1%) | June 30, 2026 |
| 20 | JPMorgan Chase & Co | 0.33% | 238K | $2.5M | +235,584 (+10,498.4%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 16 holders added 8.5M shares and 3 cut 1.4M.
HELP top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Biotech Growth Ord | 1.38% | 1.0M | $10.6M | — | June 30, 2026 |
| 2 | SEB Läkemedelsfond A (SEK) | 1.05% | 764K | $8.1M | +173,769 (+29.5%) | August 31, 2026 |
| 3 | AdvisorShares Psychedelics ETF | 0.53% | 388K | $4.1M | — | September 30, 2026 |
| 4 | Royce Small-Cap Growth Growth Svc | 0.32% | 232K | $2.4M | +77,000 (+49.7%) | June 30, 2026 |
| 5 | Fidelity Nasdaq Composite Index | 0.11% | 77K | $815,315 | +61,290 (+383.3%) | August 31, 2026 |
| 6 | Premier Miton Diversified GrB Inc | 0.10% | 76K | $798,456 | +75,683 (0.0%) | August 31, 2026 |
| 7 | Fidelity Nasdaq Composite ETF | 0.04% | 31K | $325,288 | — | September 30, 2026 |
| 8 | State Street® SPDR® S&P® Intl Sm Cp ETF | 0.04% | 30K | $311,225 | — | September 30, 2026 |
| 9 | Premier Miton Global Leaders C Acc | 0.04% | 27K | $288,089 | +27,307 (0.0%) | August 31, 2026 |
| 10 | Premier Miton Diversified Bal Gr D Inc | 0.03% | 22K | $229,895 | +21,791 (0.0%) | August 31, 2026 |
| 11 | JHVIT Health Sciences I | 0.03% | 22K | $229,378 | +21,742 (0.0%) | August 31, 2026 |
| 12 | Premier Miton Diversified Dyn Gr D Inc | 0.02% | 15K | $155,201 | +14,711 (0.0%) | August 31, 2026 |
| 13 | EQ/T. Rowe Price Health Sciences IB | 0.02% | 14K | $146,645 | +13,900 (0.0%) | August 31, 2026 |
| 14 | BSF Systematic US Eq Abs Ret A2 USD | 0.02% | 12K | $123,013 | — | December 31, 2025 |
| 15 | Premier Miton Diversified Cau Gr D Inc | 0.02% | 11K | $117,432 | +11,131 (0.0%) | August 31, 2026 |
| 16 | Invesco NASDAQ Future Gen 200 ETF | 0.01% | 10K | $107,589 | — | September 30, 2026 |
| 17 | Arrow Opportunities Alternative Series F | 0.01% | 6,120 | $64,566 | — | September 30, 2026 |
| 18 | China Universal Gbl YLBJ QDII CNH | 0.01% | 6,000 | $63,300 | +6,000 (0.0%) | June 30, 2026 |
| 19 | NEI Long Short Equity F | <0.01% | 3,580 | $37,769 | +3,580 (0.0%) | August 31, 2026 |
| 20 | T. Rowe Price Innovation Leaders ETF | <0.01% | 894 | $9,432 | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
HELP shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns HELP
Institutional investors own 42.0% of Cybin's shares and insiders 12.88%. The largest holder is VR Adviser, LLC with 5.27% of the shares (3.9M), as of June 30, 2026. Among the top 20 institutions, 16 added shares and 3 reduced their stake in the latest filings. The share count rose 8,178.4% since 2017.
Related: HELP analyst forecast, HELP key metrics. See the HELP stock overview for the latest quote and news.
HELP ownership FAQ
Who owns the most Cybin stock?
The largest shareholders of Cybin are VR Adviser, LLC (5.27%), Orbimed Advisors LLC (4.48%), Adage Capital Partners Gp LLC (4.19%), Millennium Management LLC (3.60%), Rosalind Advisors, Inc. (2.68%).
What percentage of Cybin is owned by institutions?
Institutions hold 42.0% of Cybin's shares outstanding; insiders hold 12.88%.
Which funds own Cybin?
The largest fund holders of Cybin are Biotech Growth Ord (1.38%), SEB Läkemedelsfond A (SEK) (1.05%), AdvisorShares Psychedelics ETF (0.53%), Royce Small-Cap Growth Growth Svc (0.32%), Fidelity Nasdaq Composite Index (0.11%).
How many shares of Cybin are outstanding?
Cybin has 73.1M shares outstanding, of which 58.1M are in the public float.